tnb-486

Tnb-486 has been investigated in 1 clinical trial, of which 1 is open and 0 are closed. Of the trial investigating tnb-486, 1 is phase 1 (1 open).

B-cell non-hodgkin lymphoma and Richter syndrome are the most common diseases being investigated in tnb-486 clinical trials [2].

Drug Target(s) [2]:

CD19, CD3G

1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/. [2018-07-30] [2018-08-02].

2. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.